ニュース

Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price ...
The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...
Health Affairs2 日
In Price Negotiations, Medicare Should Reassess How It Determines A ‘Qualifying Single ...
Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
Medicare to publish drugs selected for third round of price negotiations by Feb. 1
Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...
US Medicare lays out timeline for third round of drug price negotiations
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
Health Affairs6 日
Costs Of Extending The Small Molecule Exemption Period In Medicare Drug Price Negotiation
Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...
BioSpace1 日
CMS Prepares for Third Cycle of Drug Negotiations as Trump Intensifies Push To Lower Prices
The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...
JD Supra1 日
Medicare Drug Price Negotiation Program: The Inflation Reduction Act “Pill Penalty” and ...
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...
Reuters3 日
US Medicare lays out timeline for third round of drug price negotiations
said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...
National Law Review2 日
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
US court shuts down AstraZeneca's challenge to Medicare drug price plan
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...
HealthLeaders Media1 日
Medicare lays out timeline for third round of drug price negotiations
CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...